Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 11, 2020

SELL
$1.69 - $4.2 $393,656 - $978,318
-232,933 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$1.26 - $3.38 $293,495 - $787,313
232,933 New
232,933 $615,000
Q4 2019

Feb 07, 2020

SELL
$0.86 - $1.44 $270,326 - $452,639
-314,333 Closed
0 $0
Q2 2019

Aug 05, 2019

BUY
$1.25 - $3.14 $392,916 - $987,005
314,333 New
314,333 $475,000

Others Institutions Holding VSTM

About Verastem, Inc.


  • Ticker VSTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 210,000,000
  • Market Cap $1.25B
  • Description
  • Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...
More about VSTM
Track This Portfolio

Track Brighton Jones LLC Portfolio

Follow Brighton Jones LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brighton Jones LLC with notifications on news.